| Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. |
| Author(s): Fardet L, Petersen I & Nazareth I |
| Affiliations(s): Medical Research Council General Practice Research Framework
|
| Publication(s): Am J Psychiatry. 2012 May;169(5):491-7. |
| Document Type(s): Article |
| Countries: UK |
| Click here for the abstract |
C:
Y: |
Endocrinology, Mental health
2012 |
|
L:
A: |
English
Retrospective database analysis |
|
 |
| |
| |
| Severe hypertriglyceridaemia in patients treated with lipid-modifying agents. |
| Author(s): Désaméricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4. |
| Affiliations(s): 1Unité de pharmaco-épidémiologie, faculté d’odontologie UCBL, CHU de Lyon, 69372 Lyon, France
2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France
3The Health Improvement Network, SW8 3QJ London, UK
4Université de Lyon, 69003 Lyon, France
Inserm, U870, IFR62, 69008 Lyon, France
Inra, UMR1235, 69008 Lyon, France
INSA-Lyon, RMND, 69621 Villeurbanne, France
Hospices Civils de Lyon, 69008 Lyon, France |
| Publication(s): Diabetes & Metabolism
Volume 38, n° 3
pages 277-279 (juin 2012)
|
| Document Type(s): Article |
| Countries: Belgium, France, Germany, Italy, UK |
| Click here for the abstract |
C:
Y: |
Endocrinology, Metabolic Disorders , Vascular disease
2012 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Risk of cardiovascular events in patients with neuroendocrine tumors |
| Author(s): Chen CC1, Hess GP1, Liu Z2, Yao JC3, Phan AT3, Hill JW1. |
| Affiliations(s): 1 IMS Health (formerly SDI), Plymouth Meeting, PA 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX,USA |
| Publication(s): Neuroendocrinology 2011;94(Suppl.1;abstract) |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Endocrinology
2011 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Risk of hepatic and gastrointestinal events in patients with neuroendocrine tumors |
| Author(s): Hess GP1, Chen CC1, Liu Z2, Yao JC3, Phan AT3, Hill JW1 |
| Affiliations(s): 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA |
| Publication(s): Neuroendocrinology 2011;94(Suppl.1;abstract) |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Endocrinology
2011 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Risk of anxiety/depression events in patients newly diagnosed with neuroendocrine tumors |
| Author(s): Chen CC1, Hess GP1, Liu Z2, Yao JC3, Phan AT3, Hill JW1 |
| Affiliations(s): 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA |
| Publication(s): J Clin Oncol 29: 2011 (suppl; abstr e16591) |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Endocrinology
2011 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Risk of osteoporosis/osteopenia events in patients newly diagnosed with neuroendocrine tumors. |
| Author(s): Hill JW1, Chen CC1, Hess GP1, Satram-Hoang S2, Reyes CM2 |
| Affiliations(s): 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Genentech, South San Francisco, USA |
| Publication(s): J Clin Oncol 29: 2011 (suppl; abstr e16602) |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Endocrinology
2011 |
|
L:
A: |
English
Retrospective cohort analysis |
|
|
| |
| |
| Prevalence of the Metabolic Syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain. |
| Author(s): Rodríguez A, Polavieja P, Reviriego J. |
| Affiliations(s): |
| Publication(s): Endocrinol Nutr. 2010; 57(45):60-70. |
| Document Type(s): Article |
| Countries: Spain |
C:
Y: |
Endocrinology
2010 |
|
L:
A: |
Spanish
Burden of illness |
|
|
| |
| |
| Direct medical cost of Crohn disease in Spain. |
| Author(s): Casellas F, Panés J, García-Sanchez V, Ginard D, Gomollón F, Hinojosa J, Marín-Jiménez I, Barreiro M, Bastida G, Lindner L, Giménez E, Vieta A. |
| Affiliations(s): |
| Publication(s): Pharmacoeconomics Spanish Research Articles 2010;7(5):38-46. |
| Document Type(s): Article |
| Countries: Spain |
| Click here for the abstract |
C:
Y: |
Endocrinology
2010 |
|
L:
A: |
Spanish
Cost consequence |
|
|
| |
| |
| Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimen |
| Author(s): Desamericq G, Laforest L, Schwalm MS, Bourke A, Broquet M, Van Ganse E & Moulin P |
| Affiliations(s): Cegedim
|
Publication(s): ICPE 2010
Pharmacoepidemiology and Drug Safety
(19): S1-S347
|
| Document Type(s): Abstract, Poster |
| Countries: France, UK |
| Click here for the abstract |
C:
Y: |
Endocrinology, Metabolic Disorders , Miscellaneous
2010 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Cost-effectiveness of Rituximab combined with fludarabine and cyclophosphamide in previously untreated patients with chronic lymphocytic leukemia in France |
| Author(s): M. Roussel, X. Troussard, MD, A. Delmer, M. Poinso, H. Miadi Fargier |
| Affiliations(s): |
| Publication(s): ISPOR PARIS 2009 |
| Document Type(s): Poster |
| Countries: France |
C:
Y: |
Endocrinology
2009 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
 2 of 4 
|
